Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Revenue
Product sales	$ 7,950	$ 221,080
Cost of product sales	2,297	70,218
Gross profit from product sales	5,653	150,862
Other Revenue
Retained royalties	2,392	2,604
Other income	8,507	3,821
Total other revenue	10,899	6,425
Operating expenses
Selling expenses	1,236	71,994
Personnel and consulting expenses	507,478	395,023
General and administrative expenses	323,639	193,721
Total operating expenses	832,353	660,738
Operating loss	(815,801)	(503,451)
Other expense (income)
Interest expense	$ 185,862	104,786
Loss on settlement of note and warrant		$ 132,301
Loss on conversion of notes	$ 2,588
Unrealized gain on derivative instruments		$ (14,232)
Total other expense	$ 188,450	222,855
Loss before income taxes	$ (1,004,251)	$ (726,306)
Provision (benefit) for income taxes
Net loss	$ (1,004,251)	$ (726,306)
Basic and diluted loss per share	$ (0.04)	$ (0.04)
Basic and diluted weighted average number of common shares outstanding:	26,767,978	20,036,240